Systemic leakage and side effects of tumor necrosis factor alpha administration via isolated limb perfusion can be manipulated by flow rate adjustment.
Allen
R E
RE
D001132:Arm / Q000098:blood supply; D015687:Cell Hypoxia; D010478:Chemotherapy, Cancer, Regional Perfusion; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000209:etiology*; D006801:Humans; D017078:Laser-Doppler Flowmetry; D007866:Leg / Q000098:blood supply; D008833:Microcirculation; D008991:Monitoring, Physiologic; D012212:Rheology; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage / Q000009:adverse effects* / Q000032:analysis
D014409:Tumor Necrosis Factor-alpha